What HCPs Think about schools reopeningIn our latest article in the What HCPs Think series, CREATION.co’s Jamie Doggett analyses the social media activity Share XWhat HCPs Think about schools reopeninghttps://pharmaphorum.com/views-analysis-patients/what-hcps-think-about-schools-reopening/
Trump launches tirade against NIAID chief Fauci as COVID-19 crisis escalatesThe war of words between Donald Trump and his top infectious diseases expert Dr Anthony Fauci has intensified Share XTrump launches tirade against NIAID chief Fauci as COVID-19 crisis escalateshttps://pharmaphorum.com/news/trump-launches-tirade-against-niaid-chief-fauci-as-covid-19-crisis-escalates/
Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedPfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at Share XPfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedhttps://pharmaphorum.com/news/pfizer-ready-to-roll-if-biontech-covid-19-shot-is-approved/
UK government signs contract for COVID-19 challenge trialThe UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will Share XUK government signs contract for COVID-19 challenge trialhttps://pharmaphorum.com/news/uk-government-signs-contract-for-covid-19-challenge-trial/
UK trials digital ‘health passport’ to help borders reopenRegular fliers are used to long queues to clear security – but a rigorous COVID-19 testing regime could Share XUK trials digital ‘health passport’ to help borders reopenhttps://pharmaphorum.com/news/uk-trials-digital-health-passport-to-help-borders-reopen/
Sanofi preps trials of second COVID-19 shot, as Russia approves anotherSanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after Share XSanofi preps trials of second COVID-19 shot, as Russia approves anotherhttps://pharmaphorum.com/news/sanofi-preps-trials-of-second-covid-19-shot-as-russia-approves-another/
Coronavirus re-infection case confirmed in the USThere is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of Share XCoronavirus re-infection case confirmed in the UShttps://pharmaphorum.com/news/coronavirus-re-infection-case-confirmed-in-the-us/
J&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’Johnson & Johnson has paused further dosing in its COVID-19 vaccine clinical trial following an “unexplained illness” in Share XJ&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’https://pharmaphorum.com/news/jjs-late-stage-covid-19-vaccine-trial-halted-after-unexplained-illness/
Spotlight on COVID-19 antibody therapies after Trump’s recoveryThe spotlight remains on the potential of antibody therapies as a possible way out of the COVID-19 pandemic Share XSpotlight on COVID-19 antibody therapies after Trump’s recoveryhttps://pharmaphorum.com/news/spotlight-on-covid-19-antibody-therapies-after-trumps-recovery/
